181 related articles for article (PubMed ID: 12396475)
1. Inhibitory action of a macrolide antibiotic, roxithromycin, on co-stimulatory molecule expressions in vitro and in vivo.
Suzuki M; Asano K; Yu M; Hisamitsu T; Suzaki H
Mediators Inflamm; 2002 Aug; 11(4):235-44. PubMed ID: 12396475
[TBL] [Abstract][Full Text] [Related]
2. Suppressive activity of a macrolide antibiotic, roxithromycin on co-stimulatory molecule expression on mouse splenocytes in vivo.
Kawazu K; Kurokawa M; Asano K; Mita A; Adachi M
Mediators Inflamm; 2000; 9(1):39-43. PubMed ID: 10877454
[TBL] [Abstract][Full Text] [Related]
3. Suppression of co-stimulatory molecule expressions on splenic B lymphocytes by a macrolide antibiotic, roxithromycin in vitro.
Asano K; Suzuki M; Shimane T; Suzaki H
Int Immunopharmacol; 2001 Jul; 1(7):1385-92. PubMed ID: 11460318
[TBL] [Abstract][Full Text] [Related]
4. Suppressive effects of co-stimulatory molecule expressions on mouse splenocytes by anti-allergic agents in vitro.
Ito J; Asano K; Tryka E; Kanai K; Yamamoto S; Hisamitsu T; Suzaki H
Mediators Inflamm; 2000; 9(2):69-75. PubMed ID: 10958379
[TBL] [Abstract][Full Text] [Related]
5. Suppressive effects of anti-allergic agent suplatast tosilate (IPD-1151T) on the expression of co-stimulatory molecules on mouse splenocytes in vivo.
Kurokawa M; Kawazu K; Asano K; Fumio K; Mita A; Adachi M
Mediators Inflamm; 2001 Dec; 10(6):333-7. PubMed ID: 11817674
[TBL] [Abstract][Full Text] [Related]
6. Suppressive activity of a macrolide antibiotic, roxithromycin, on pro-inflammatory cytokine production in vitro and in vivo.
Suzaki H; Asano K; Ohki S; Kanai K; Mizutani T; Hisamitsu T
Mediators Inflamm; 1999; 8(4-5):199-204. PubMed ID: 10704073
[TBL] [Abstract][Full Text] [Related]
7. Influence of anti-allergic agents on in vivo expression of co-stimulatory molecules in normal mice.
Tryka E; Asano K; Ito J; Hisamitsu T; Suzaki H
In Vivo; 1999; 13(5):415-20. PubMed ID: 10654195
[TBL] [Abstract][Full Text] [Related]
8. Interferon-beta up-regulates the expression of co-stimulatory molecules CD80, CD86 and CD40 on monocytes: significance for treatment of multiple sclerosis.
Marckmann S; Wiesemann E; Hilse R; Trebst C; Stangel M; Windhagen A
Clin Exp Immunol; 2004 Dec; 138(3):499-506. PubMed ID: 15544628
[TBL] [Abstract][Full Text] [Related]
9. Influence of a macrolide antibiotic, roxithromycin, on mast cell growth and activation in vitro.
Shimane T; Asano K; Suzuki M; Hisamitsu T; Suzaki H
Mediators Inflamm; 2001 Dec; 10(6):323-32. PubMed ID: 11817673
[TBL] [Abstract][Full Text] [Related]
10. Suppression of matrix metalloproteinase-9 production from neutrophils by a macrolide antibiotic, roxithromycin, in vitro.
Kanai K; Asano K; Hisamitsu T; Suzaki H
Mediators Inflamm; 2004 Dec; 13(5-6):313-9. PubMed ID: 15770046
[TBL] [Abstract][Full Text] [Related]
11. [Suppressive activity of a macrolide antibiotic, roxithromycin, and its metabolites on co-stimulatory molecule expression].
Suzuki M; Asano K; Susaki H
Jpn J Antibiot; 2001 Dec; 54 Suppl C():91-3. PubMed ID: 12575428
[No Abstract] [Full Text] [Related]
12. Inhibitory action of roxithromycin on tumour necrosis factor-alpha production from mast cells in vitro.
Shimane T; Asano K; Mizutani T; Suzaki H
In Vivo; 1999; 13(6):503-6. PubMed ID: 10757045
[TBL] [Abstract][Full Text] [Related]
13. Differential effects of iron deficiency on the expression of CD80 and CD86 co-stimulatory receptors in mitogen-treated and untreated murine spleen cells.
Kuvibidila SR; Porretta C
J Cell Biochem; 2002; 86(3):571-82. PubMed ID: 12210763
[TBL] [Abstract][Full Text] [Related]
14. [Suppressive effect of roxithromycin on co-stimulatory molecule expression].
Ito J; Suzuki M; Asano K; Suzaki H
Jpn J Antibiot; 2003 Apr; 56 Suppl A():131-3. PubMed ID: 14679767
[No Abstract] [Full Text] [Related]
15. Administration of dendritic cells transduced with antisense oligodeoxyribonucleotides targeting CD80 or CD86 prolongs allograft survival.
Liang X; Lu L; Chen Z; Vickers T; Zhang H; Fung JJ; Qian S
Transplantation; 2003 Aug; 76(4):721-9. PubMed ID: 12973117
[TBL] [Abstract][Full Text] [Related]
16. Co-stimulation with 4-1BB ligand allows extended T-cell proliferation, synergizes with CD80/CD86 and can reactivate anergic T cells.
Habib-Agahi M; Phan TT; Searle PF
Int Immunol; 2007 Dec; 19(12):1383-94. PubMed ID: 17977894
[TBL] [Abstract][Full Text] [Related]
17. Proteoglycan isolated from Phellinus linteus activates murine B lymphocytes via protein kinase C and protein tyrosine kinase.
Kim GY; Park SK; Lee MK; Lee SH; Oh YH; Kwak JY; Yoon S; Lee JD; Park YM
Int Immunopharmacol; 2003 Sep; 3(9):1281-92. PubMed ID: 12890426
[TBL] [Abstract][Full Text] [Related]
18. Splenic dendritic cells pulsed with Ixodes ricinus tick saliva prime naive CD4+T to induce Th2 cell differentiation in vitro and in vivo.
Mejri N; Brossard M
Int Immunol; 2007 Apr; 19(4):535-43. PubMed ID: 17344202
[TBL] [Abstract][Full Text] [Related]
19. [Effect of roxithromycin in modifying the expression of costimulatory molecules].
Mita A; Kurokawa M; Kawazu K; Adachi M
Jpn J Antibiot; 2000 Jan; 53 Suppl A():78-82. PubMed ID: 10756458
[No Abstract] [Full Text] [Related]
20. [Suppressive effect of roxithromycin on the induction of IL-2 responsiveness by DF-stimulated lymphocytes from patients with bronchial asthma].
Nakajima T; Yoshizawa I; Kawano Y; Noma T
Arerugi; 1996 Jun; 45(6):554-61. PubMed ID: 8776950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
